Recently, America’s biopharmaceutical companies joined the American Cancer Society for the Cancer Action Network Clinical Trials Policy Forum at the Mayo Clinic in Jacksonville, Florida
More than 100 attendees joined—including physicians, researchers, patient advocates, business leaders, media and policymakers—to help raise awareness about clinical trials in Florida and review strategies for recruiting more participants.
“Clinical trials are integral in advancing research and in providing patients with new treatment options,” said Emma Van Hook, director of Policy and Research at PhRMA. “The benefits of clinical trials stretch so far beyond each patient, providing knowledge and insights that can lead to the next breakthrough.”